In 2012, on the occasion of 20th anniversary, National Engineering Research Center for Refractories, registered in Sinosteel LIRR, got ＂ Excellent Achievement Prize＂ from National Development and Reform Commission ...In 2012, on the occasion of 20th anniversary, National Engineering Research Center for Refractories, registered in Sinosteel LIRR, got ＂ Excellent Achievement Prize＂ from National Development and Reform Commission for its demonstration function and outstanding achievments.展开更多
The Szent-Gyorgyi Prize for Progress in Cancer Research is a prestigious scientific award established by the National Foundation for Cancer Research(NFCR)—a leading cancer research charitable organization in the Unit...The Szent-Gyorgyi Prize for Progress in Cancer Research is a prestigious scientific award established by the National Foundation for Cancer Research(NFCR)—a leading cancer research charitable organization in the United States that is committed to supporting scientific research and public education relating to the prevention,early diagnosis,better treatments,and ultimately,a cure for cancer.Each year,the Szent-Gyorgyi Prize honors an outstanding researcher,nominated by colleagues or peers,who has contributed outstanding,significant research to the fight against cancer,and whose accomplishments have helped improve treatment options for cancer patients.The Prize also promotes public awareness of the importance of basic cancer research and encourages the sustained investment needed to accelerate the translation of these research discoveries into new cancer treatments.This report highlights the pioneering work led by the 2015 Prize winner,Dr.Frederick Alt.Dr.Alt's work in the area of cancer genetics over four decades has helped to shape the very roots of modern cancer research.His work continues to profoundly impact the approaches that doctors around the globe use to diagnose and treat cancer.In particular,his seminal discoveries of gene amplification and his pioneering work on molecular mechanisms of DNA damage repair have helped to usher in the era of genetically targeted therapy and personalized medicine.展开更多
The Szent-Gyrgyi Prize for Progress in Cancer Research is a prestigious scientific award established by the National Foundation for Cancer Research(NFCR)—a leading cancer research charitable organization in the Unite...The Szent-Gyrgyi Prize for Progress in Cancer Research is a prestigious scientific award established by the National Foundation for Cancer Research(NFCR)—a leading cancer research charitable organization in the United States that is committed to supporting innovative cancer research on the global scale that aims to cure cancer. Each year, the Szent-Gyrgyi Prize honors an outstanding researcher whose original discoveries have expanded our understanding of cancer and resulted in notable advances in cancer prevention, diagnosis, or treatment. The prize also promotes public awareness of the importance of basic cancer research and encourages the sustained investment needed to accelerate the translation of these research discoveries into new cancer treatments. This report highlights the history and mission of the Szent-Gyrgyi Prize, its role in promoting discovery-oriented cancer research, and the pioneering work led by the 2014 prize winner, Dr. James Allison. Dr. Allison's work in the area of cancer immunotherapy led to the successful development of immune checkpoint therapy, and the first drug approved by the United States Food and Drug Administration for the treatment of metastatic melanoma.展开更多
IN September 1992,at the crosing ceremonies of the ChinaInternational Acrobatics Festival in Wuhan,the Chinese Acro-baties Association issued its first group of Baixi(one hundredacrobatics) prizes,the highest honor in...IN September 1992,at the crosing ceremonies of the ChinaInternational Acrobatics Festival in Wuhan,the Chinese Acro-baties Association issued its first group of Baixi(one hundredacrobatics) prizes,the highest honor in China to oe awardee toacrobats.Its aim is to commend people who have made the mostoutstanding contributions to the nation’s acrobatics since the foundingof the People’s Republic of China in 1949.展开更多
文摘In 2012, on the occasion of 20th anniversary, National Engineering Research Center for Refractories, registered in Sinosteel LIRR, got ＂ Excellent Achievement Prize＂ from National Development and Reform Commission for its demonstration function and outstanding achievments.
文摘The Szent-Gyorgyi Prize for Progress in Cancer Research is a prestigious scientific award established by the National Foundation for Cancer Research(NFCR)—a leading cancer research charitable organization in the United States that is committed to supporting scientific research and public education relating to the prevention,early diagnosis,better treatments,and ultimately,a cure for cancer.Each year,the Szent-Gyorgyi Prize honors an outstanding researcher,nominated by colleagues or peers,who has contributed outstanding,significant research to the fight against cancer,and whose accomplishments have helped improve treatment options for cancer patients.The Prize also promotes public awareness of the importance of basic cancer research and encourages the sustained investment needed to accelerate the translation of these research discoveries into new cancer treatments.This report highlights the pioneering work led by the 2015 Prize winner,Dr.Frederick Alt.Dr.Alt's work in the area of cancer genetics over four decades has helped to shape the very roots of modern cancer research.His work continues to profoundly impact the approaches that doctors around the globe use to diagnose and treat cancer.In particular,his seminal discoveries of gene amplification and his pioneering work on molecular mechanisms of DNA damage repair have helped to usher in the era of genetically targeted therapy and personalized medicine.
文摘The Szent-Gyrgyi Prize for Progress in Cancer Research is a prestigious scientific award established by the National Foundation for Cancer Research(NFCR)—a leading cancer research charitable organization in the United States that is committed to supporting innovative cancer research on the global scale that aims to cure cancer. Each year, the Szent-Gyrgyi Prize honors an outstanding researcher whose original discoveries have expanded our understanding of cancer and resulted in notable advances in cancer prevention, diagnosis, or treatment. The prize also promotes public awareness of the importance of basic cancer research and encourages the sustained investment needed to accelerate the translation of these research discoveries into new cancer treatments. This report highlights the history and mission of the Szent-Gyrgyi Prize, its role in promoting discovery-oriented cancer research, and the pioneering work led by the 2014 prize winner, Dr. James Allison. Dr. Allison's work in the area of cancer immunotherapy led to the successful development of immune checkpoint therapy, and the first drug approved by the United States Food and Drug Administration for the treatment of metastatic melanoma.
文摘IN September 1992,at the crosing ceremonies of the ChinaInternational Acrobatics Festival in Wuhan,the Chinese Acro-baties Association issued its first group of Baixi(one hundredacrobatics) prizes,the highest honor in China to oe awardee toacrobats.Its aim is to commend people who have made the mostoutstanding contributions to the nation’s acrobatics since the foundingof the People’s Republic of China in 1949.
